Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China. Latest news

Different medical institutions have selected different imported and domestic brand instruments: 38 domestic and 58 imported.

A new consortium spearheaded by the New York Genome Center aims to foster and organize genomic COVID-19 research in the New York metropolitan area. With approximately $2.5 million in philanthropy funding to start, the COVID-19 Genomics Rese

Genomic epidemiology papers from two independent teams are exploring potential sources of recent SARS-CoV-2 introductions to Chinas Guangdong province and to Connecticut, respectively, revealing some of the complex dynamics of the coronavir

In the months since SARS-CoV-2 emerged and began spreading, researchers have been attempting to collect new data to understand the virus and COVID-19 disease it causes. But they have also been digging into sequence and gene expression data

Two months into the COVID-19 pandemic, the number of SARS-CoV-2 molecular diagnostic tests across the US remains woefully inadequate. According to the COVID Tracking Project, a volunteer effort to track testing across the country headed by

A new study launched by scientists at Hannover Medical School (MHH) in Germany is determined to find out why patients respond differently to COVID-19. With the help of industry partners including Bionano Genomics, Genoox, Rescale, and Amazo

South Korean molecular diagnostics firm Seegene announced after the close of the market on Tuesday that the US Food and Drug Administration has granted Emergency Use Authorization for the firms Allplex 2019-nCoV Assay, a real-time RT-PCR te

Exact Sciences reported on Tuesday after the close of the market that its preliminary first quarter revenues are expected to rise about 115 percent, despite the negative impact of the COVID-19 pandemic on orders for its Cologuard colorectal

Austrian biopharma firm Viravaxx said on Tuesday that it is collaborating with the Medical University of Vienna to create a platform for diagnostic and vaccine research into COVID-19. The collaborators will use a protein microarray comprisi

A group of life sciences and bioinformatics companies have banded together in the race to find treatments, vaccines, and a cure for COVID-19. The fledgling EndPandemic National Data Consortium said last week that seven firms have signed on

Envisagenics announced Tuesday it has entered into a research program agreement with Johnson Johnsons Lung Cancer Initiative (LCI.) Under the terms of the agreement, Envisagenics will build predictive models for lung cancer progression and